Leuthold Group’s CONMED CNMD Stock Holding History

Leuthold Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,024	Closed	-$556K	–	188
2018 Q3	$556K	Buy	+7,024	New	+$543K	0.06%	153

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Leuthold Group's CNMD Position: Q4 2018 in Review

Leuthold Group sold out of CONMED (CNMD) in Q4 2018, closing a stake of 7,024 shares — an estimated $556K sold.

Leuthold Group first reported a position in CNMD in Q3 2018 and held it in 1 quarter. The position peaked at $556K in Q3 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q4 2018.

Leuthold Group reported no remaining CONMED position as of Q4 2018 after selling out during the quarter.
Leuthold Group sold 7,024 CONMED shares in Q4 2018, an estimated $556K.
Leuthold Group first reported a position in CONMED in Q3 2018 and held it in 1 quarter.
Leuthold Group's CONMED position peaked at $556K in Q3 2018.
207 funds tracked by Wall St. Rank held CONMED as of Q4 2018.

Based on Leuthold Group's 13F filing for Q4 2018, filed 14 Feb 2019.